Wirksamkeit kognitiver Interventionen für Schizophrenie (Q59769658)

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

Integrating cognitive-behavioral psychotherapy for persons with schizophrenia into a psychiatric rehabilitation program: results of a three year trial

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

Psychoeducational psychotherapy for schizophrenic patients and their key relatives or care‐givers: results of a 2‐year follow‐up

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

A pilot study of functional Cognitive Behavioral Therapy (fCBT) for schizophrenia

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

Evaluation of Treatment-Resistant Schizophrenia

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

Cognitive therapy and recovery from acute psychosis: A controlled trial

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

Cognitive therapy and recovery from acute psychosis: a controlled trial. I. Impact on psychotic symptoms

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

Cognitive Therapy and Recovery from Acute Psychosis: a Controlled Trial

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

Tayside-Fife clinical trial of cognitive-behavioural therapy for medication-resistant psychotic symptoms. Results to 3-month follow-up

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

A cognitive model of persecutory delusions

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

London-East Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis. II: Predictors of outcome

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

A cognitive model of the positive symptoms of psychosis

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

A meta-analysis of the effects of cognitive therapy in depressed patients

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

Cognitive therapy for psychosis in schizophrenia: an effect size analysis

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

A pilot study evaluating the effectiveness of individual inpatient cognitive-behavioural therapy in early psychosis

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

Meta-analysis of screening and diagnostic tests

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

The continuity of psychotic experiences in the general population.

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

Cognitive behaviour therapy for schizophrenia

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

Compliance therapy in psychotic patients: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

London-east Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis. III: Follow-up and economic evaluation at 18 months

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

London-East Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis. I: effects of the treatment phase

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

Randomised controlled trial of cognitive-behavioural therapy in early schizophrenia: acute-phase outcomes.

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

Kognitive Verhaltenstherapie von Wahn und Halluzinationen

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

Relevant dimensions of delusions: continuing the continuum versus category debate

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

Correlates and long-term consequences of poor insight in patients with schizophrenia. A systematic review

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

Effectiveness of psychoeducation for relapse, symptoms, knowledge, adherence and functioning in psychotic disorders: a meta-analysis

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

Choice of the Metric for Effect Size in Meta-analysis

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

Metacognitive training in schizophrenia: from basic research to knowledge translation and intervention

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

Treatment integrity in psychotherapy research: analysis of the studies and examination of the associated factors

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

Efficacy of psychological therapy in schizophrenia: conclusions from meta-analyses

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

Cognitive-behavioral therapy and clozapine for clients with treatment-refractory schizophrenia

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

Insight into schizophrenia: the effects of cognitive behavioural therapy on the components of insight and association with sociodemographics--data on a previously published randomised controlled trial

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

Cognitive behavioral therapy for schizophrenia: an empirical review

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

Cognitive therapy for schizophrenia: a preliminary randomized controlled trial

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

Barriers to employment for people with schizophrenia

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

The file drawer problem and tolerance for null results

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

Effektivität psychologischer Therapien von Panik und Agoraphobie: Meta-Analysen auf Störungsebene

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

North Wales randomized controlled trial of cognitive behaviour therapy for acute schizophrenia spectrum disorders: outcomes at 6 and 12 months

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

A trial of two cognitive-behavioural methods of treating drug-resistant residual psychotic symptoms in schizophrenic patients: I. Outcome

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

Cognitive–behavioural therapy in first-episode and early schizophrenia

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

Is there evidence that cognitive behaviour therapy is an effective treatment for schizophrenia? A cautious or cautionary tale?

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

Cognitive-behavioural techniques for general psychiatrists in the management of patients with psychoses

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

Outcomes of an effectiveness trial of cognitive-behavioural intervention by mental health nurses in schizophrenia

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

Effectiveness of a brief cognitive-behavioural therapy intervention in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

Cognitive-behavioural therapy for refractory psychotic symptoms of schizophrenia resistant to atypical antipsychotic medication. Randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

What are the effects of group cognitive behaviour therapy for voices? A randomised control trial

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021

The effect of cognitive behavioral treatment on the positive symptoms of schizophrenia spectrum disorders: a meta-analysis

1 reference

https://api.crossref.org/works/10.1026/0033-3042.59.4.217

7 January 2021